New soluble CSF-1R-dimeric mutein with enhanced trapping of both CSF-1 and IL-34 reduces suppressive tumor-associated macrophages in pleural mesothelioma

sCSF-1R<sub>M149K</sub>-Fc efficiently traps both CSF-1 and IL-34 and inhibits CSF-1R signaling, monocyte survival and suppressive macrophage differentiation induced by pleural mesothelioma cells producing CSF-1 and IL-34, as well as restores cytotoxic T-cell responses. sCSF-1R<sub>M149K</sub>-Fc has therapeutic potential vs other therapies under development targeting single components of this complex cytokine pathway involved in cancer.

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-03-01
DOI
https://doi.org/10.1136/jitc-2024-010112
Citations
4
Primary Topic
Occupational and environmental lung diseases
Type
article
Field-Weighted Citation Impact
6.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New soluble CSF-1R-dimeric mutein with enhanced trapping of both CSF-1 and IL-34 reduces suppressive tumor-associated macrophages in pleural mesothelioma

Romain Humeau, Carole Guillonneau, Noémie Joalland, Erwan Mortier et al.
4 citations
Journal for ImmunoTherapy of Cancer
Occupational and environmental lung diseases
6.07
article

New soluble CSF-1R-dimeric mutein with enhanced trapping of both CSF-1 and IL-34 reduces suppressive tumor-associated macrophages in pleural mesothelioma

Romain Humeau, Carole Guillonneau, Noémie Joalland, Erwan Mortier, Sophie Deshayes, Christophe Blanquart, Agnès Quéméner, Judith Fresquet, Apolline Salama, Séverine Remy, Ignacio Anegón, Mike Maillasson, Héloïse LeBihan
article en
4 citations

Abstract

sCSF-1R<sub>M149K</sub>-Fc efficiently traps both CSF-1 and IL-34 and inhibits CSF-1R signaling, monocyte survival and suppressive macrophage differentiation induced by pleural mesothelioma cells producing CSF-1 and IL-34, as well as restores cytotoxic T-cell responses. sCSF-1R<sub>M149K</sub>-Fc has therapeutic potential vs other therapies under development targeting single components of this complex cytokine pathway involved in cancer.

Journal for ImmunoTherapy of CancerVol. 13(3)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Centre Hospitalier Universitaire de Nantes (FR), Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (FR), Nantes Université (FR)
Infrastructures en Biologie Santé et Agronomie, Agence Nationale de la Recherche, Fondation ARC pour la Recherche sur le Cancer, Ligue Contre le Cancer, Labex
Openalex Percentile: Top 4%
Occupational and environmental lung diseases
6.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.